通过调控NF-κB/IκB炎症信号转导通路治疗多器官功能障碍综合征的实验研究
|
摘要
目的：多器官功能障碍综合征(MODS)是全身感染、创伤、烧伤、重症胰腺炎、心肺复苏等疾病中存在的一个共同的难点问题。MODS中致炎因子的过度生成和中性粒细胞、单核／巨噬细胞凋亡障碍是导致疾病发生恶化的两个重要因子。而NF-κB的活化则是其中一个中心环节。在以往的研究中，许多学者试图通过阻断或封闭炎症因子来治疗MODS，但效果均不理想，甚至增加了死亡率。其主要原因可能为炎症因子及代谢产物数量众多，仅针对其中一种或几种进行干预往往达不到预期目的。NF-κB是一种重要的转录因子复合物，它通过激活细胞因子级联反应，生成促炎介质，抑制炎性细胞凋亡在MODS的病理生理过程中起重要作用。因此通过抑制上游转导通路NF-κB的活化，在较高水平上对产生炎症介质的总环节进行控制，是防治MODS新的曙光。本研究以腺病毒转载的IκB基因从中心静脉途径注入增加野生型IκB的表达，即通过直接增加细胞内NF-κB内源性抑制物水平以抑制其活化，从而有效阻断MODS发生发展的通路。
方法：第一部分：成年SD大鼠28只，随机分为7个时相：注射病毒前，注射病毒后1d、3d、7d、14d、21d及28d。将重组腺病毒转载的AdLacZ基因经中心静脉途径导入SD大鼠体内，以X-gal染色法检测腺病毒介导的标识基因(LacZ)在大鼠体内的表达部位和时间。第二部分：30只大鼠随机分为三组：A组(正常对照组)；B组(MODS24小时组)；C组(MODS7天组)，A组大鼠缓慢注入生理盐水0.25ml／kg，B、C组大鼠缓慢注入油酸0.25ml／kg，4小时后B、C组经中心静脉途径注入脂多糖3.5mg／kg(体积1ml)。观察三组大鼠从致伤开始后的生理状态、刺激反应、活动度、死亡率、各脏器功能的生化指标及形态学改变等情况。第三部分；50只大鼠随机分为五组：A组(正常对照组)；B组(MODS损伤1天组)；C组(MODS损伤7天组)；D组(腺病毒转载IκB治疗1天组)；E组(腺病毒转载IκB治疗7天组)。每组10只。A组大鼠缓慢注入生理盐水0.25ml／kg，B、C、D、E组大鼠缓慢注入油酸0.25ml／kg，4小时后颈部备皮消毒，经中心静脉途径A组缓慢注入生理盐水1ml，B、C、D、E组注入脂多糖3.5mg／kg(体积1ml)。同时D、E组注入滴度为1×10~9空斑形成单位(pfu)的腺病毒转载的IκB基因1ml。观察五组大鼠从致伤开始后1天、7天的生理状态、刺激反应、活动度、死亡率、各脏器功能的生化指标及形态学改变、血浆肿瘤坏死因子α(TNF-α)、白介素—6(IL-6)含量、肺、肝组织中NF-κBP65蛋白、Fas蛋白、FasL蛋白的表达
结果：
1．注射AdLacZ(1×10~9pfu／mL)后1d，在大鼠肺、肝、肾组织即有少量LacZ表达，3d后大鼠肺、肝、肾、脾组织表达明显，7d达高峰，到14d开始下降，28d基本消失。
2．B、C组大鼠血肌酐、谷丙转氨酶、总胆红素、肌酸磷酸肌酶水平较A组明显升高(P＜0.05)，D、E组血肌酐、谷丙转氨酶、总胆红素、肌酸磷酸肌酶水平与A组相比无显著差异(P＞0.05)；D组谷丙转氨酶、总胆红素、肌酸磷酸肌酶水平较B组降低(P＜0.05)，而血肌酐水平无显著差异(P＞0.05)；E组血肌酐、谷丙转氨酶、总胆红素、肌酸磷酸肌酶水平较C组明显降低(P＜0.05)；B组与C组，D组与E组相比血肌酐、谷丙转氨酶、总胆红素、肌酸磷酸肌酶水平均无显著差异(P＞0.05)。B、C、D、E组动脉血氧分压均较A组有所降低(P＜0.05)；但E组动脉血氧分压较C组明显升高(P＜0.05)D组与B组、B组与C组、D组与E组相比动脉血氧分压水平均无显著差异(P＞0.05)PH值C组与A、B组相比有所降低(P＜0.05)，其余各组相比均无差异(P＞0.05)；PaCO_2五组之间比较均无显著性差异(P＞0.05)；
3．A、C、E三组大鼠血液中TNF-α、IL-6值比较：其中TNF-α浓度以C组最高，A组最低，E组居中，三组间比较均有显著的统计学差异(P＜0.05)。IL-6浓度以C组最高，A组最低，E组居中，三组间比较均有显著的统计学差异(P＜0.05)。见表3。
4．在A组肺组织内可见NF-κBP65阳性细胞表达多分布于肺泡巨噬细胞、中性粒细胞和血管内皮细胞，胞浆阳性。C组在油酸—内毒素刺激后可见阳性细胞主要以细胞核为主，染色重，胞浆也有少量染色，但染色程度较正常组织浅。E组经IκB基因治疗后见阳性细胞分布于胞浆和胞核，胞核内阳性细胞较C组明显减少。免疫组化评分C组(9.38±1.06)最高，A组(0.9±0.88)最低，E组(3.78±1.20)居中，三组间比较有显著统计学差异(P＜0.05)。在A组肝组织内可见NF-κBP65阳性细胞表达于肝细胞胞浆。C组在油酸—内毒素刺激后可见阳性细胞主要以细胞核为主，染色重，胞浆也有少量染色，但染色程度较正常组织浅，E组经IκB基因治疗后见阳性细胞分布于胞浆和胞核，胞核内阳性细胞较C组明显减少。免疫组化评分C组(9.75±1.39)最高，A组(0.70±0.82)最低，E组(4.21±1.56)居中，三组间比较有显著统计学差异(P＜0.05)。
5．A组大鼠肺、肝组织中可见NF-βBP65、Fas、FasL蛋白表达，B、C组肺、肝组织中NF-κBP65、Fas、FasL蛋白表达较A组明显升高，以肺组织升高幅度最大。D、E组肺、肝组织中NF-κBP65、Fas、FasL表达较B、C组明显下降
结论：
1．经中心静脉途径注入腺病毒转载的IκB基因，可在肺、肝、肾、脾内高效表达，可用于相关系统疾病的基因治疗。
2．经中心静脉途径注入腺病毒转载的IκB基因在脑内始终无表达，不适于中枢神经系统疾病的治疗
3．油酸／脂多糖序贯损伤可成功复制大鼠MODS模型。是研究以肺启动机制较好的MODS模型。
4．经中心静脉途径导入腺病毒转载的IκB基因，可降低MODS大鼠血肌酐、谷丙转氨酶、总胆红素、肌酸磷酸肌酶水平，改善动脉血氧分压。
5．经中心静脉途径注入腺病毒转载的IκB基因，可降低MODS大鼠血液中炎性因子TNF-α、IL-6的含量，抑制肝、肺组织NF-κB的活化(核转移)，减轻NF-Kbp65蛋白表达。
6．经中心静脉途径导入腺病毒转载的IκB基因，可明显降低肝、肺组织的Fas和FasL表达，减轻MODS大鼠器官组织过度的细胞凋亡。
7．经中心静脉途径注入腺病毒转载的IκB基因治疗MODS的机制可能为直接增加野生型IκB的表达，抑制NF-κB活化，从而抑制炎症级联反应，抑制过度的细胞凋亡，治疗MODS。其具体的机制尚有待于进一步研究。
Objective: multiple organ disfunction syndrome was a corporatedifficulty problem in systemic inflammation, trauma, burn, and diseases.overexpression of inflammation factors and handicap of monocyte andmacrophages apoptosis had deteriorated diseases .one of the focus tacheswas the activation of nuclear factor -κB .in the past studies,manyscholars wanted to therapy multiple organ disfunction syndrome byinterdiction expression of inflammation factors .but the effect was notperfect,some even increased mortality rate.the main cause was likely tointerventens a sort of inflammatorymediators and metabolizablesubstances could not carried anticipatable point, nuclear factor -κBwas a importmont transfer factor compound.it had importment functionin the pathophysiological process of multiple organ disfunctionsyndrome by activated series reactions of cytokines ,createdinflammatory mediators and controlled cells apoptosis.so it was a newmethods to therapy multiple organ dis function syndrome by modulatednuclear factor -κB activation .in the sudy , we want to interdictdevelopmental of multiple organ disfunction syndrome by directly increase endogenic inhibitor of NF-κB, inhibition NFκ-B activation andinflammation factor and enzyme Releasing by infusing IκB genetansported adenovirus through central vein.
Methods:part one: pathogen-free rats were randomly divided intoseven scheduling: before inject adenovirus , afte inject adenovirus oneday, afte inject adenovirus three days, afte inject adenovirus seven days,afte inject adenovirus fourteen days, afte inject adenovirus twenty-onedays, afte inject adenovirus twenty-eight days,Recombinant adenovirusvector containing LacZ was transferred to SD rats by injecting intointernal jugular vein. To identify the sites and periods of LacZ geneexpression,X-gal staining was used to detectβ-gal level and period ofLacZ gene expression of different organs in the transfected andnon-transfected rats at different time intervals, part two: 30pathogen-free rats were randomly divided into three groups: A group(control group) , B group (MODS24 hours), C group(MODS72hours),The rats of A groups was infused Saline at the dose of 0.25ml/kg, Band C groups were infused oleic acid at the dose of 0.25ml/kg andlipopolysaccharide at the dose of 3.5ml/kg through central vein(4 hoursinterval), the stimulatory reaction, activity, the morality rate and thefunction of the heart, liver, kidney, and lung after injection wereobserved, part three: 50 pathogen-free rats were randomly divided intofive groups: A group (control group), B group (MODS24 hours), Cgroup (MODS72hours), D group (AdIκB therapy one day), E group (AdIκB therapy seven day). The rats of A groups was infused Saline atthe dose of 0.25ml/kg, B, C, D and E groups were infused oleic acid atthe dose of 0.25ml/kg and lipopolysaccharide at the dose of 3.5ml/kgthrough central vein(4 hours interval). At the same time, C and D groupwere infused 1ml IκB gene tansported adenovirus (tite:1×10~9pfu), thestimulatory reaction, activity, th morality rate and the function of theheart ,liver, kidney, and lung were observed after injection one day andsenven days. plasm content of TNF-α, IL-6, expression of NF-κBP65 inlung and liver tissue through immunohistochemical staining andwestblotting means, expression of Fas and Fas ligand in lung and livertissue through westblotting means were recorded after injection oneand seven 7 days.
Result:
1. The 1st day after the injection, the lungs, livers, kidneys ,and spleensexpressed few level ofβ-gal ; the 3rd day after the injection, the lungs,livers, kidneys and spleens expressedβ-gal obviously ;their peak levelswere on the 7th days;theβ-gal level decreased on the 14th day;.β-galexpression disappeared in most organs except lungs on the 28th days.Inall animals ,the brain did not appear anyβ-gal expression
2. the level of creatinine, alanine aminotranferase ,total bilirubin ,creatinephosphokinase in group B and C were significantly higher than Agroup(P＜0.05).but its in D and E group had little differences than in Agroup(P＞0.05), the level of alanine aminotranferase, total bilirubin, creatine phosphokinase in group D was significantly lowerer than Bgroup (P＜0.05). but the level of creatinine had no difference(P＞0.05).the level of creatinine, alanine aminotranferase, total bilirubin, creatinephosphokinase in group E were significantly lower than C group(P＜0.05).there were no difference in B and C group, D and Egroup(P＞0.05).the lever of partial pressure of arterial oxygen(PaO2) inB, C, D, E group was significantly lower in group A (p＜0.05),but thelever of partial pressure of arterial oxygen(PaO2) in E group wassignificantly higher in group C(p＜0.05), there were no difference in Band D group, B and C group, D and E group(P＞0.05), the lever of PH inC group was lower than A and B group(p＜0.05).although PaCO2 in fivegroup had little differences.
3. the serum content of TNF-αwas the highest in group C and the lowestin group A(group A vs C and group E vs C, P＜0.05,respectively). theserum content of IL-6 was the highest in group C and the lowest ingroup A(group A vs C and group E vs C, P＜0.05,respectively).
4. in lung of group A,the male cells of NF-κBP65 were distribution inpulmonary alveolus macrophage ,neutrophilic granulocyte and vascularendothelial cell .cytoplasmic is male .in group C the male cells were innuclei mainly , a small quantity male cell were in cytoplasmic butstaining was superficial than the normal group, in group E. the malecells were in nuclei and cytoplasmic, the male cells in nuclei reducedobviously than group C. the scale of immunohistochemistry was the highest in group C and the lowest in group A(group A vs C group E vsAand group E vs C, P＜0.05, respectively). in liver of group A, the malecells of NF-κBP65 were distribution in hepatic cells , cytoplasmic ismale in group C the male cells were in nuclei mainly, a small quantitymale cell were in cytoplasmic but staining was superficial than thenormal group, in group E. the male cells were in nuclei and cytoplasmic.the male cells in nuclei reduced obviously than group C. the scale ofimmunohistochemistry was the highest in group C and the lowest ingroup A(group A vs C group E vs Aand group E vs C, P＜0.05,respectively).
5.. the experssions of NF-κBP65、Fas and FasL protein in group B andC were significantly higher than A group.but its in D and E group hadlittle differences than in A group, the level of NF-κd3P65、Fas and FasLprotein in group E was significantly lowerer than C group
Conclusions:
1. The adenovirus-mediated IκB gene transfer in internal jugular veinmay be an effective approach of gene therapy in some diseases such aslungs,livers, and kidneys.
2. The adenovirus-mediated IκB gene transfer in internal jugular veincan not be an approach of gene therapy in central nervous systemdiseases
3.the model established by injection of oleic acid and lipopolysaccharidesubsequently is a suitable modle for the studies of the primordial role of lung in the pathogenesis of the multiple organ disfunction syndrome.
4..Infusing IκB gene tansported adenovirus through central vein canreduced the lever of creatinine, alanine aminotranferase ,total bilirubin,creatine phosphokinase in multiple organ disfunction syndrome rats.andalso improved the lever of partial pressure of arterial oxygen.
5. Infusing IκB gene tansported adenovirus through central vein canreduced the lever of the serum content of TNF-αand IL-6,and suppressthe activation of nuclear factor-κB in lung and liver tissues,accordinglyabated expression of NF-κBP65.
6. Infusing IκB gene tansported adenovirus through central vein canreduced the expression of Fas and Fas ligand in lung and liver tissues,accordingly alleviate the excessive cells apoptosis in multiple organdisfunction syndrome rats.
7..To increased expression of IκB gene can relieve rat multiple organdisfunction syndrome result in infuse by internal jugular vein.themechanism of therapy multiple organ disfunction syndrome was enhanceendogenic inhibitor of NFκ-B inhibition NF-κB activation andinflammation cascade reaction
方法：第一部分：成年SD大鼠28只，随机分为7个时相：注射病毒前，注射病毒后1d、3d、7d、14d、21d及28d。将重组腺病毒转载的AdLacZ基因经中心静脉途径导入SD大鼠体内，以X-gal染色法检测腺病毒介导的标识基因(LacZ)在大鼠体内的表达部位和时间。第二部分：30只大鼠随机分为三组：A组(正常对照组)；B组(MODS24小时组)；C组(MODS7天组)，A组大鼠缓慢注入生理盐水0.25ml／kg，B、C组大鼠缓慢注入油酸0.25ml／kg，4小时后B、C组经中心静脉途径注入脂多糖3.5mg／kg(体积1ml)。观察三组大鼠从致伤开始后的生理状态、刺激反应、活动度、死亡率、各脏器功能的生化指标及形态学改变等情况。第三部分；50只大鼠随机分为五组：A组(正常对照组)；B组(MODS损伤1天组)；C组(MODS损伤7天组)；D组(腺病毒转载IκB治疗1天组)；E组(腺病毒转载IκB治疗7天组)。每组10只。A组大鼠缓慢注入生理盐水0.25ml／kg，B、C、D、E组大鼠缓慢注入油酸0.25ml／kg，4小时后颈部备皮消毒，经中心静脉途径A组缓慢注入生理盐水1ml，B、C、D、E组注入脂多糖3.5mg／kg(体积1ml)。同时D、E组注入滴度为1×10~9空斑形成单位(pfu)的腺病毒转载的IκB基因1ml。观察五组大鼠从致伤开始后1天、7天的生理状态、刺激反应、活动度、死亡率、各脏器功能的生化指标及形态学改变、血浆肿瘤坏死因子α(TNF-α)、白介素—6(IL-6)含量、肺、肝组织中NF-κBP65蛋白、Fas蛋白、FasL蛋白的表达
结果：
1．注射AdLacZ(1×10~9pfu／mL)后1d，在大鼠肺、肝、肾组织即有少量LacZ表达，3d后大鼠肺、肝、肾、脾组织表达明显，7d达高峰，到14d开始下降，28d基本消失。
2．B、C组大鼠血肌酐、谷丙转氨酶、总胆红素、肌酸磷酸肌酶水平较A组明显升高(P＜0.05)，D、E组血肌酐、谷丙转氨酶、总胆红素、肌酸磷酸肌酶水平与A组相比无显著差异(P＞0.05)；D组谷丙转氨酶、总胆红素、肌酸磷酸肌酶水平较B组降低(P＜0.05)，而血肌酐水平无显著差异(P＞0.05)；E组血肌酐、谷丙转氨酶、总胆红素、肌酸磷酸肌酶水平较C组明显降低(P＜0.05)；B组与C组，D组与E组相比血肌酐、谷丙转氨酶、总胆红素、肌酸磷酸肌酶水平均无显著差异(P＞0.05)。B、C、D、E组动脉血氧分压均较A组有所降低(P＜0.05)；但E组动脉血氧分压较C组明显升高(P＜0.05)D组与B组、B组与C组、D组与E组相比动脉血氧分压水平均无显著差异(P＞0.05)PH值C组与A、B组相比有所降低(P＜0.05)，其余各组相比均无差异(P＞0.05)；PaCO_2五组之间比较均无显著性差异(P＞0.05)；
3．A、C、E三组大鼠血液中TNF-α、IL-6值比较：其中TNF-α浓度以C组最高，A组最低，E组居中，三组间比较均有显著的统计学差异(P＜0.05)。IL-6浓度以C组最高，A组最低，E组居中，三组间比较均有显著的统计学差异(P＜0.05)。见表3。
4．在A组肺组织内可见NF-κBP65阳性细胞表达多分布于肺泡巨噬细胞、中性粒细胞和血管内皮细胞，胞浆阳性。C组在油酸—内毒素刺激后可见阳性细胞主要以细胞核为主，染色重，胞浆也有少量染色，但染色程度较正常组织浅。E组经IκB基因治疗后见阳性细胞分布于胞浆和胞核，胞核内阳性细胞较C组明显减少。免疫组化评分C组(9.38±1.06)最高，A组(0.9±0.88)最低，E组(3.78±1.20)居中，三组间比较有显著统计学差异(P＜0.05)。在A组肝组织内可见NF-κBP65阳性细胞表达于肝细胞胞浆。C组在油酸—内毒素刺激后可见阳性细胞主要以细胞核为主，染色重，胞浆也有少量染色，但染色程度较正常组织浅，E组经IκB基因治疗后见阳性细胞分布于胞浆和胞核，胞核内阳性细胞较C组明显减少。免疫组化评分C组(9.75±1.39)最高，A组(0.70±0.82)最低，E组(4.21±1.56)居中，三组间比较有显著统计学差异(P＜0.05)。
5．A组大鼠肺、肝组织中可见NF-βBP65、Fas、FasL蛋白表达，B、C组肺、肝组织中NF-κBP65、Fas、FasL蛋白表达较A组明显升高，以肺组织升高幅度最大。D、E组肺、肝组织中NF-κBP65、Fas、FasL表达较B、C组明显下降
结论：
1．经中心静脉途径注入腺病毒转载的IκB基因，可在肺、肝、肾、脾内高效表达，可用于相关系统疾病的基因治疗。
2．经中心静脉途径注入腺病毒转载的IκB基因在脑内始终无表达，不适于中枢神经系统疾病的治疗
3．油酸／脂多糖序贯损伤可成功复制大鼠MODS模型。是研究以肺启动机制较好的MODS模型。
4．经中心静脉途径导入腺病毒转载的IκB基因，可降低MODS大鼠血肌酐、谷丙转氨酶、总胆红素、肌酸磷酸肌酶水平，改善动脉血氧分压。
5．经中心静脉途径注入腺病毒转载的IκB基因，可降低MODS大鼠血液中炎性因子TNF-α、IL-6的含量，抑制肝、肺组织NF-κB的活化(核转移)，减轻NF-Kbp65蛋白表达。
6．经中心静脉途径导入腺病毒转载的IκB基因，可明显降低肝、肺组织的Fas和FasL表达，减轻MODS大鼠器官组织过度的细胞凋亡。
7．经中心静脉途径注入腺病毒转载的IκB基因治疗MODS的机制可能为直接增加野生型IκB的表达，抑制NF-κB活化，从而抑制炎症级联反应，抑制过度的细胞凋亡，治疗MODS。其具体的机制尚有待于进一步研究。
Objective: multiple organ disfunction syndrome was a corporatedifficulty problem in systemic inflammation, trauma, burn, and diseases.overexpression of inflammation factors and handicap of monocyte andmacrophages apoptosis had deteriorated diseases .one of the focus tacheswas the activation of nuclear factor -κB .in the past studies,manyscholars wanted to therapy multiple organ disfunction syndrome byinterdiction expression of inflammation factors .but the effect was notperfect,some even increased mortality rate.the main cause was likely tointerventens a sort of inflammatorymediators and metabolizablesubstances could not carried anticipatable point, nuclear factor -κBwas a importmont transfer factor compound.it had importment functionin the pathophysiological process of multiple organ disfunctionsyndrome by activated series reactions of cytokines ,createdinflammatory mediators and controlled cells apoptosis.so it was a newmethods to therapy multiple organ dis function syndrome by modulatednuclear factor -κB activation .in the sudy , we want to interdictdevelopmental of multiple organ disfunction syndrome by directly increase endogenic inhibitor of NF-κB, inhibition NFκ-B activation andinflammation factor and enzyme Releasing by infusing IκB genetansported adenovirus through central vein.
Methods:part one: pathogen-free rats were randomly divided intoseven scheduling: before inject adenovirus , afte inject adenovirus oneday, afte inject adenovirus three days, afte inject adenovirus seven days,afte inject adenovirus fourteen days, afte inject adenovirus twenty-onedays, afte inject adenovirus twenty-eight days,Recombinant adenovirusvector containing LacZ was transferred to SD rats by injecting intointernal jugular vein. To identify the sites and periods of LacZ geneexpression,X-gal staining was used to detectβ-gal level and period ofLacZ gene expression of different organs in the transfected andnon-transfected rats at different time intervals, part two: 30pathogen-free rats were randomly divided into three groups: A group(control group) , B group (MODS24 hours), C group(MODS72hours),The rats of A groups was infused Saline at the dose of 0.25ml/kg, Band C groups were infused oleic acid at the dose of 0.25ml/kg andlipopolysaccharide at the dose of 3.5ml/kg through central vein(4 hoursinterval), the stimulatory reaction, activity, the morality rate and thefunction of the heart, liver, kidney, and lung after injection wereobserved, part three: 50 pathogen-free rats were randomly divided intofive groups: A group (control group), B group (MODS24 hours), Cgroup (MODS72hours), D group (AdIκB therapy one day), E group (AdIκB therapy seven day). The rats of A groups was infused Saline atthe dose of 0.25ml/kg, B, C, D and E groups were infused oleic acid atthe dose of 0.25ml/kg and lipopolysaccharide at the dose of 3.5ml/kgthrough central vein(4 hours interval). At the same time, C and D groupwere infused 1ml IκB gene tansported adenovirus (tite:1×10~9pfu), thestimulatory reaction, activity, th morality rate and the function of theheart ,liver, kidney, and lung were observed after injection one day andsenven days. plasm content of TNF-α, IL-6, expression of NF-κBP65 inlung and liver tissue through immunohistochemical staining andwestblotting means, expression of Fas and Fas ligand in lung and livertissue through westblotting means were recorded after injection oneand seven 7 days.
Result:
1. The 1st day after the injection, the lungs, livers, kidneys ,and spleensexpressed few level ofβ-gal ; the 3rd day after the injection, the lungs,livers, kidneys and spleens expressedβ-gal obviously ;their peak levelswere on the 7th days;theβ-gal level decreased on the 14th day;.β-galexpression disappeared in most organs except lungs on the 28th days.Inall animals ,the brain did not appear anyβ-gal expression
2. the level of creatinine, alanine aminotranferase ,total bilirubin ,creatinephosphokinase in group B and C were significantly higher than Agroup(P＜0.05).but its in D and E group had little differences than in Agroup(P＞0.05), the level of alanine aminotranferase, total bilirubin, creatine phosphokinase in group D was significantly lowerer than Bgroup (P＜0.05). but the level of creatinine had no difference(P＞0.05).the level of creatinine, alanine aminotranferase, total bilirubin, creatinephosphokinase in group E were significantly lower than C group(P＜0.05).there were no difference in B and C group, D and Egroup(P＞0.05).the lever of partial pressure of arterial oxygen(PaO2) inB, C, D, E group was significantly lower in group A (p＜0.05),but thelever of partial pressure of arterial oxygen(PaO2) in E group wassignificantly higher in group C(p＜0.05), there were no difference in Band D group, B and C group, D and E group(P＞0.05), the lever of PH inC group was lower than A and B group(p＜0.05).although PaCO2 in fivegroup had little differences.
3. the serum content of TNF-αwas the highest in group C and the lowestin group A(group A vs C and group E vs C, P＜0.05,respectively). theserum content of IL-6 was the highest in group C and the lowest ingroup A(group A vs C and group E vs C, P＜0.05,respectively).
4. in lung of group A,the male cells of NF-κBP65 were distribution inpulmonary alveolus macrophage ,neutrophilic granulocyte and vascularendothelial cell .cytoplasmic is male .in group C the male cells were innuclei mainly , a small quantity male cell were in cytoplasmic butstaining was superficial than the normal group, in group E. the malecells were in nuclei and cytoplasmic, the male cells in nuclei reducedobviously than group C. the scale of immunohistochemistry was the highest in group C and the lowest in group A(group A vs C group E vsAand group E vs C, P＜0.05, respectively). in liver of group A, the malecells of NF-κBP65 were distribution in hepatic cells , cytoplasmic ismale in group C the male cells were in nuclei mainly, a small quantitymale cell were in cytoplasmic but staining was superficial than thenormal group, in group E. the male cells were in nuclei and cytoplasmic.the male cells in nuclei reduced obviously than group C. the scale ofimmunohistochemistry was the highest in group C and the lowest ingroup A(group A vs C group E vs Aand group E vs C, P＜0.05,respectively).
5.. the experssions of NF-κBP65、Fas and FasL protein in group B andC were significantly higher than A group.but its in D and E group hadlittle differences than in A group, the level of NF-κd3P65、Fas and FasLprotein in group E was significantly lowerer than C group
Conclusions:
1. The adenovirus-mediated IκB gene transfer in internal jugular veinmay be an effective approach of gene therapy in some diseases such aslungs,livers, and kidneys.
2. The adenovirus-mediated IκB gene transfer in internal jugular veincan not be an approach of gene therapy in central nervous systemdiseases
3.the model established by injection of oleic acid and lipopolysaccharidesubsequently is a suitable modle for the studies of the primordial role of lung in the pathogenesis of the multiple organ disfunction syndrome.
4..Infusing IκB gene tansported adenovirus through central vein canreduced the lever of creatinine, alanine aminotranferase ,total bilirubin,creatine phosphokinase in multiple organ disfunction syndrome rats.andalso improved the lever of partial pressure of arterial oxygen.
5. Infusing IκB gene tansported adenovirus through central vein canreduced the lever of the serum content of TNF-αand IL-6,and suppressthe activation of nuclear factor-κB in lung and liver tissues,accordinglyabated expression of NF-κBP65.
6. Infusing IκB gene tansported adenovirus through central vein canreduced the expression of Fas and Fas ligand in lung and liver tissues,accordingly alleviate the excessive cells apoptosis in multiple organdisfunction syndrome rats.
7..To increased expression of IκB gene can relieve rat multiple organdisfunction syndrome result in infuse by internal jugular vein.themechanism of therapy multiple organ disfunction syndrome was enhanceendogenic inhibitor of NFκ-B inhibition NF-κB activation andinflammation cascade reaction
引文
[1] Murphy SJ, Chong H, Bell S, et al. Novel integrating adanoviral/retroviral hybrid vector for gene therapy. [J] Hum Gene Ther, 2002,13(6): 745-760.
[2] Sandig V, Youil R,Bett AJ,et al. Optimization of the helper-dependent adenovirvus system for production and potency in virvo.[J] Proc Natl Acad Sci 2000; 97(3): 1002-1007
[3] Fathallah Shaykh HM, Kafrouni AI, Zhao LJ, Smith GM, Forman J. Gene transfer into brain parenchyma elicits antitumor effects. [J] Cancer Res, 2000; 60(1): 1797-1799
[4] Schoggins JW, Gall JG, Falck-Pedersen E. Subgroup B and f fiber chimeras eliminate normal adenovirus type 5 vector transduction in vitro and in vivo. [J] Virol, 2003, 77(2): 1039-1048.
[5] Lin H,Parmacek MS,Morle G, et, al.Expression of recombinant gene in myocardium in vivo aflerdirect injection pf DNA[J]. Circulation, 1990, 82(6): 2217-2221
[6] Xing Z, Braciak Z, Jordana M, et al.Adenovirus-mediated cytokine gene transfer at tissue sites. Overexpression of IL-6 induces lymphocytic hyperplasia in the lung [J] Immunol 1994,153(11): 4059 - 4069
[7] Mohr L, Shankara S, Yoon SK, et ai. Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene. [J] Hepatology, 2000; 31(3): 606-614
[8] Bout A, Perricaudet M, Basking et al.Lung gene therapy:in vivo adenovirusmediated gene transfer to rhesus monkey airway epithelium. Hum Gene ther.1994; 5(1):3-10
[9] Maruyama H, Rakow TL, Maruyama IN,.Synaptic exocytosis and nervous system development impaired in caenorhabditis elegans unc-13 mutants. [J]Neuroscience, 2001,104(2):287-294.
[10] Li JJ, Ueno H, Pan Y, et al. Percutaneous transluminal gene transfer into canine myocardium in vivo by replication-defective adenovirus, [J]Cardiovasc Res,1995,30(1):97.
[1] Shimada H,Moriwaki Y, Kurosawa H, et al.Infammatory mediator and organ dysfunction syndrome.Nippon Geka Gakkai Zasshi 1998 Aug:99(8):490-6
[2] Murakami M,Murai N,Kusano M,Organ failure during the perioperative period:pathophysiology and strategy. Nippon Geka Gakkai Zasshi 1998 Aug:99(8): 518-22.
[3] Kushimoto S,Yamaoto Y.SIRS:clinical entity, definitions,and the significance. Nippon Rinsho 1999 Jan; 57(1): 227-35.
[4] Sato N,Endo S,Ikeda K,et al.SIRS in surgical stress.Rinsho Byori 2000 Jan;48(6):521-6
[5] Hirota M,Nozawa F, Okabe A,et al.SIRS and CARS:discussion based on the pathologic condition of acute pancreatitis.Rinsho Byori 2000 Jan;48(6):527-32.
[6] 胡森，盛志勇。MODS动物模型研究进展。中国危重病急救医学，1999，8(11)：504—507。
[7] Bhatti AR, Micusan VV.A mouse modle for staphylococcal entreotoxins toxicity.Microbiol 1996;86(349):247-53.
[8] Hu Sen, Sheng Zhi-yong,Zhou Bao-tong,et al study on delay two-phase mulitiple organ dysfunction syndrome Chin Med J, 1998,111:101-108.
[9] Soreide E,Harboe S,Sondenaa K,et al.Severe ARDS may cause right heart failure with extreme hepatomegaly but without hepatic failure[J].Acta Anaesthesiol Scand,2002,46(7):906-907.
[10] Hristova M,Yordanov M, Ivanvska N,Effrct of gangchinoline in murine modles of multiple organ dysfunction syndrome and septic shock[J] Inflamm Res,2003,52(1): 1-7.
[11] Scillia P, Kafi S A,Melot C,et al.Oleic acid -induced lung injury:thinsection CT evaluation in dogs[J]Radiology,2001,219(3):724-731.
[12] Davidson KG,Berstrn AD,Barr HA, et al.Lung function,permeability,and surfactant composition in oleic acid induced acute lung injury in ratsJ] Am J Physiol Lung Cell Mol Physiol,2000,279(6):L1091-1102.
[1] FangWH,YaoYM,ShiZY, etal. 2002. Lipopolysaccharide-binding protein and lipopolysaccharide receptor CD14 gene expression after thermal injury and its potential mechanism. J Trauma,2002,53:957～967.
[2] Holmes CL,Russell JA,Walley KR.Genetic polymorphisms in sepsis and septic shock:role in prognosis and potential for therapy.chest,2003,124:1103-1115.
[3] Khadaroo RG, Fan J,Powers KA et al.Impaired induction of IL-10 expression in the lung following hemorrhagic shock.Shock,2004,22:333-339.
[4] Senftleben U,Karin M.The IKK/NF-κB pathway.Crit Care Med,2002,30:S18-26.
[5] Takeda K,Kaisho T, Akira.Toll-like receptors. Annu Rev Immunol, 2003, 21: 335-376
[6] 萨姆布鲁克 J，弗里奇 EFy，曼尼阿蒂斯 T 著，金冬燕。黎孟枫译：分子克隆实验指南(第二版) 科学出版社，北京 1992，P881—898。
[7] Soslow RA,Dannenberg AJ,Rush D,et al.cox-2 is expressed in human pulmonary,colonic,and mammary tumors.Cancer,2000,87(12):2637-2645
[8] Yves Le Tulzo, Robert Shenkar, Debra Kaneko, et al.Hemorrhage Increases Cytokine Expression in Lung Mononuclear Cells in Mice. Involvement of Catecholamines in Nuclear Factor-κB Regulation and Cytokine Expression J.Clin. Invest. 1997 99:1516-1524
[9] Keith R. Walley, TreenaE. Et al.Modulation of Proinflammatory Cytokines by Nitric Oxide in Murine Acute Lung Injury Am. J. Respir. Crit. Care Med. 1999; 160:698-704
[10] E. Abraham; R. Wunderink; H. Silverman; T. M. et al.Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study GroupJAMA, Mar 1995; 273:934 - 941.
[11] C. J. Fisher Jr; J. F. Dhainaut; S. M. Opal; et al.Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase Ⅲ rhIL-1ra Sepsis Syndrome Study GroupJAMA, Jun 1994; 271:1836 - 1843.
[12] Kox WJ,Volk T, Kox CN. Immunomodulatory therapies in sepsis.[J].Intensive Care Med,2000,26(Suppl 1):S124-128.
[13] Huber TS,Gaines GC,Welbom B,et al. Anticytokine therapies for acute inflammation and the systemic inflammatory response syndrome: IL-10 and ischemia/reperfusion injury as a new paradigm. [J]Shock,2000,13(6):432-434
[14] Marumo T, Schini-kerth VB,Busse R.Vascular endothelial growth factor activates nuclear factor -kappaB and induces monocyte chemoattractant protein- 1 in bovine retinal endothelial cells[J].Diabetes, 1999,48(5)/: 1131-1138
[15] Yamamoto Y, Gaynor RB, Therapeutic potential of inhibition of the NF-kB pathway in the trearment of inflammation and cancer[J]. J Clin Invest, 2001,107(2): 135-142
[16] Barnes PJ, Anti-inflammatiory actions of glucocorticoids: molecular mechanism [J]. Clin Sci(Colch), 1998, 9496): 557-566
[17] Meng L,Mohan R,Kwoh BH,et al.Epoxomicin,a potent and selective proteasome inhibitor, exhibits in vivo anti-inflammatory activity[J].Pro Natl Acad Sci USA, 1999,96(180:10403-10408
[18] Zandi E, Chen Y, Karin M, et al. Direct Phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappab-bound substrate[J]. Science, 1998,281:1360-1363
[19] Hess DC,Howard E,Cheng C,et al.hypetonic mannitol loading of NF-ksppaB transcription factor decoys in human brain microvascular endothelial cells blocks upregulation of ICAM-1 [J].Stroke,200,31 (5): 1179-1186
[20] Grisenbach V, Scheid P, Hillery E,etal Anti-inflmmatory gene therapy directed at airway epithelium [J] Gene Ther,2000,7:306-313
[21] Marcel L,Florian G, Ines B, et al. Tumor necrosis factor induced hypatocyte apoptosis proceeds liver failure in experimental murine shock models.Am J Pathol, 1995,146:1220-1226.
[22] Hivammaatsu M,Hotchkiss RS,Kaarl IE, et al. Cecal ligation and puncture induceds apoptosis in thymus,apleen,lungand gut by an endotoxin and TNF-independent pathway. Shock, 1997,7:247-253.
[23] Efron PA,Tinsley K,Minnich DJ et al.Increased lymphoid tissue apoptosis in baboons with bacteremic shock.Shock 2004,21:566-571.
[24] Guillon V, Tribut O,Amlot L,et al.Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcame.Shock,2002,18:487-494.
[25] ONeill AJ,Doyle BT, Moloyy E et al.Gene expression profile of inflammatory neutrophils: alterations in the inhibitors of apoptosis proptosis protein during spontaneous and delayed apoptosis.Shock,2004,21:512-518.
[26] Tinsley KW, Grayson MH,Swanson PE et al.Sepsis induces apoptosis and profound depletion of splenic interdigiting and follicular dendritic cells.J Immunol,2003,171:909-914.
[27] Woodside KJ,Spies M,Wu XW et al.Decreased lymphocyte apoptosis by anti-tumor necrosis factor antibody in Peyers patches after severe burn.Shock,2003,20:70-73.
[28] Rieux-Lancat F, Ledeisy F, Hovroz C,et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science, 1995, 268:1347-1349.
[29] Elizabeth D E,Papathanassoglon RN,Jan A,et al.Expression of Fas(CD95)and Fas legend on peripheral blood mononuclear cells in critical illness and association with multiorgan dysfunction severity and survival.Crit Care Med,2001 vol,29,NO4:709-718
[1] [1] Tilney NL,Bailey GL,Mogan AP, et al. Sequential system failure after rupture of abdominal aortic aneurysms:an unsolved problem in postoperative care.Ann Surg 1973;178(2)117-122.
[2] Eiseman B,et al.Multiple organ failure. Surg Gynecol Obsted 1977; 144: 323-326
[3] Yao YM, Redl H, Bahrami S,et,al.The inflammatory basis of trauna/shock-associated multiple organ failure [J]Inflam Res, 1998,47:201
[4] Baue AE.Multiple,progress, or sequential system failure:a syndrome of the 1970s.Arch Surg 1975;110(7):779-781.
[5] Fry DE,Pearlstein L,Fulton RL,et al. Multiple system organ failure: the role of uncontrolled infection.Arch Surg 1980; 115(2): 136-140.
[6] Goris JA, et al. Multiple- organ failure:generalized autodestructive inflammation? Arch Surg 1985; 120: 1109-1115.
[7] Bunt TJ.Non-directed relaparotomy for intra-abdominal sepsis:a futile procedure.Am Surg 1986;52(6):294-298
[8] 周韶霞，邱海波，王爱琴，多器官功能障碍综合征与全身炎症反应综合征[J]．铁道医学，1998，26(1)：4
[9] Bone RC,Balk RA,Cerra FB,et al.The ACCP/SCCM Consensus conference on sepsis and organ failure [J].Chest, 1992,101 (6): 1644.
[10] Bone R C,Immunologic dissonance:a continuing evolution in our cmderstanding of the systemic inflammatory response syndrome and the multiple organ dysfunction syndrome.Ann Interm Med, 1996,125:680-681.
[11] Bone R C. Sir Isaac menton:sepsis,SIRS,and CARS.Crit Care Med, 1996, 24(7): 1125-1128
[12] Hivamaatsu M,Hotchkiss R S,Kaarl IE,et al.Cecal ligation and puncture (CLP)induced apoptosis in thymus,apleen,lung and gut by an etdotoxin and TNF-independent pathway.Shock, 1997,7:247-253.
[13] Rieux-Lancat F, Ledeist F, Hovroz C,et al. Mutation in Fas associated with human-Lymphoproliferative-syndrome-and-autoimmunity.Science, 1995,268:1347-1349.
[14] Elizabeth D E,Papathanassoglon RN,Jan A,et al.Expression of Fas(CD95)and Fas legend on peripheral blood mononuclear cells in critical illness and association with multiorgan dysfunction severity and survival.Crit Care Med, 2001 vol, 29, NO4:709-718
[15] Jimenez ME,Watson W G,Parodo J,et al.Dysregulated expression of neutrophil apotosis in the systemic inflammatory response syndrome.Arch Surg, 1997, 132: 1263-1270.
[16] Nolan B,Collette H,Baker S,et al.Inhibition of neutrophil apoptosis after sever trauma is NF-kappabeta dependent.Journal of Trauma 2000 vol 48,NO4:599-605
[17] Westendorp RGL,Langer mans JAM,Huizinga TWJ,et al.Genetic influence on cytokine.Lancent1997;349:170-173.
[18] van Deventer SH,Stokker P.Genomice of the sepsis syndrome.In: Marshall JC,Cohen J(eds) Immune response in the critically ill.Berlin:Springer-Verlag, 2000, 22-36
[19] Muzio M,Mantovani A.Toll-like receptors.Microbers Infect,2002,2:251-255.
[20] Sen R, Bzltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a.posttranslational mechanism. [J]. Cell,1986,47:921-928
[21] Rahman I,MacNee W. Role of transcription factors in inflammatory lung diseases. Thorax,1998;53:601-612
[22] Karin M,Ben-Neriah Y, Phosphorylation meets ubiquination:the control of NF-kB activity[J].Annu Rev Immunol.2000,18,621-663
[23] Bothrer H,Nawroth PP.Nuclear factor Kb-a new therapeutic approach?Intensive Care Med,1998,24:1129-1130.
[24] Blackwell TS,Christman JW.The role of nuclear factor-kappaB in cytokine gene regulation.Am J Respir cell Mol Biol, 1997,17:3-9.
[25] Nemeth ZH,Hasko G,Vizi ES.Pyrrolidine dithiocarbamate augements IL-10,inhibits TNF-alpha,MIP-1 alpha,IL-12 and nitric oxide production and protects from the lethal effect of endotoxin.Shock,1998,10:49-53.
[26] Lo CJ,Cryer HG, Fu M,et al.Regulation of
[27] 钟林。内皮细胞与多器官功能不全。见：罗正，主编。休克学。第一版。天津：天津科学技术出版社，2001，812—820。
[28] Nakamori Y, Koh T, Ogura H,et al.Enhanced expression of intranuclear NF-kappa B in primed polymorphonuclear leukocytes in systemic inflammatory response syndrome patients.J Trauma,2003,54(2):253-260.
[29] Kettritz R,Choi M,Rolle S,et al.Integrin and cytokines activate nuclear transcription factor-kappaB in human neutrophils.J Biol Chem,2004,279(4): 2657-2665
[30] Abraham E.Nuclear factor-kappaB and its role in sepsis-associated organ failure.J Infect Dis,2003,187(Suppl 2)S364-S369
[31] Foulds S,Galustain C,Mansfield AO,et al.Transcription factor NF-kappa B expression and postsurgical organ dysfunction.Ann Surg,2001,233:70-78
[32] Mustapha S,Kirhner A,De Moissac D,et al. A direct requirement of nuclear factor-kappa B for suppression of apotosis in ventricular myocytes.Am J Physiol Heart Circ Physiol,2000,279(3):H939-945
[33] Marumo T, Schini-kerth VB,Busse R.Vascular endothelial growth factor activates nuclear factor -kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells[J].Diabetes, 1999,48(5)/: 1131-1138
[34] Yamamoto Y, Gaynor RB, Therapeutic potential of inhibition of the NF-kB pathway in the trearment of inflammation and cancer[J]. J Clin Invest, 2001,107(2): 135-142
[35] Barnes PJ, Anti-inflammatiory actions of glucocorticoids: molecular mechanism [J]. Clin Sci(Colch), 1998, 9496): 557-566
[36] Meng L,Mohan R,Kwoh BH,et al.Epoxomicin,a potent and selective proteasome inhibitor, exhibits in vivo anti-inflammatory activity[J].Pro Natl Acad Sci USA, 1999,96(180:10403-10408
[37] Zandi E, Chen Y, Karin M, et al. Direct Phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappab-bound substrate[J]. Science, 1998,281:1360-1363
[38] Hess DC,Howard E,Cheng C,et al.hypetonic mannitol loading of NF-ksppaB transcription factor decoys in human brain microvascular endothelial cells blocks upregulation of ICAM-1 [J].Stroke,200,31 (5): 1179-1186
[1] Tilney NL,Bailey GL,Mogan AP,et al. Sequential system failure after rupture of abdominal aortic aneurysms :an unsolved problem in postoperative care.Ann Surg 1973;178(2)117-122.
[2] Schuster HP Infection as a cause of multiple organ failure. Definition, pathophysiology and diagnostic parameters.[J] Anasth intensivether Notfall Med,1989,24(4):206-211.
[3] YaoYM, RedIH, Bahram S, et al The inflammatory basis of trauma/ shock- associated multiple organ failure. [J] Inflamm Res, 1998, 47(5): 201-210.
[4] Bone RC,Balk RA,Cerra FB,et al.The ACCP/SCCM Consensus conference on sepsis and organ failure [J].Chest,1992,101(6):1644.
[5] Bone R C,Immunologic dissonance:a continuing evolution in our cmderstanding of the systemic inflammatory response syndrome and the multiple organ dysfunction syndrome.Ann Interm Med, 1996,125:680-681.
[6] Kox WJ,Volk T,Kox CN. Immunomodulatory therapies in sepsis.[J].Intensive Care Med, 2000,26(Suppl1):S124-128.
[7] Huber TS,Gaines GC, Welbom B,et al. Anticytokine therapies for acute inflammation and the systemic inflammatory response syndrome: IL-10 and ischemia/reperfusion injury as a new paradigm. [J]Shock,2000,13(6):432-434
[8] Kerr JF,Wyllie AH,Currie AR .Apoptosis; A basic biological phenomenon with wide-ranging implications in tissue kinitics. Br J Cancer 1972;26(4):239-257.
[9] Kerr JF,Winterford CM,Harmon BV.Apoptosis .its significance in cancer and cancer therapy. Cancer1994;73(8):2013-2026.
[10] Ogawa N,Dang H,Talal N.Apoptosis and autoimmunity.J Autoimmun 1995; 8(1): 1-19.
[11] White E,Sabbatini RDebbas M,et al.The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha.Mol Cell Biol.1992;12(6):2570-80
[12] Gougeon ML, Montagnier L.Apoptosis in AIDS.Science 1993;260(5112): 1269-1270.
[13] Raff MC,Barres BA,Burne JF,et al.Programmed cell death and the control of cell survival: lesions from nervous system.Science 1993;262(5134):695-670
[14] Thompson CB.Apotosis in the pathogenesis and treatment of disease. Science 1995;267(5203):1456-1462.
[15] Ayala A,Karr SM,Evans TA,et al.Factors responsible for peritoneal granulocyte apoptosis during sepsis J Surg Res,1997,69(1):67-75.
[16] Meldrum DR,Tumor necrosis factor in the heart .Am J Physiol, 1998, 274(3pt2): R577-595
[17] Hamada E,Nishida T,Uchiyama Y, et al. Activation of kupffer cells and caspase-3 involved in rat hepatocyte apoptosis induced by endotoxin.J Hepatol 1999;30(5):807-818
[18] Leist M,Grantner F,Bohlinger I, et al.Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure experimental murine shock models.Am J Pathol 1995;146(5):1220-1234.
[19] Leist M,Grantner F,Naumann H,et al. Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepototoxins. Gastroenterology 1997; 112(3): 923-924.
[20] Wang Jianghuai,Redmond HP,Watson RWG, et al.Role of lipopolysaccharide and tumor necrosis factor-alpha in induction of hepatocyte necrosis. Am J Physiol, 1995,269(2pt1):G297-304.
[21] Keel M,Ungethum U,Steckholzer U,et al.Interleukin -10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis., Blood,1997,90(9):3356-3363.
[22] Cheng J ,T Zhou, C Liuet,et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule Science, 1994,263:1759.
[23] Ungethwn U,Keel M,Trentz Q,et al.Increased expression of apoptosis-inducing proteins Fas antigen and Fas ligand on mononuclear cells of septic patients. Langenbecka Arch Chir Suppl Kongressbd,1997,114:623-625.
[24] Ertel W,Keel M,Ungethum U,et al.Proinflammatory cytokines regulate apoptosis of granulocytes during systemic inflammation. Langenbecka Arch Chir Suppl Kongressbd, 1997,114:627-629.
[25] Alfred Ayala, Ying Xin Xu, Carol A. Ayala, et al.Increased Mucosal B-Lymphocyte Apoptosis During Polymicrobial Sepsis Is a Fas Ligand But Not an Endotoxin-Mediated Process Blood, Feb 1998; 91: 1362 - 1372.
[26] Williams TE,Ayala A,Chaudry TH.Inducible macrophage apotosis following sepsis is mediated by cysteine protease activation and nitric oxide release. J Surg Res,1997,70(2):113-118.
[27] Ford H, Watkins S, Reblock K, et al .The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis. J Pediatr Surg, 1997, 32(2):275-282.
[28] Marchant A,Deviere J,Byi B,et al. Interleukin-10 production during septicaemia. Lancet, 1994,343:707.
[29] Neidhardt, Regula MD; Keel, Marius MD; Steckholzer, Ursula BS et al. Relationship of Interleukin-10 Plasma Levels to Severity of Injury and Clinical Outcome in Injured Patients. Journal of Trauma-Injury Infection & Critical Care. 1997,42(5):863-871.
[30] Ayala A, Chaudry H. Immune dysfunction in murine polymicrobial sepsis: mediators, macrophages, lymphocytes and apoptosis. Shock, 1996, 6 (suppl1): S27-38.
[31] Cox GIL-10 enhances resolution of pulmonary inflammatory in vivo by promoting apotosis of neutrophils.Am J Physiol,1996,271(4pt1):L566-571.
[32] Marcel L,Florian G, Ines B, et al. Tumor necrosis factor induced hypatocyte apoptosis proceeds liver failure in experimental murine shock models.Am J Pathol, 1995,146:1220-1226.
[33] Hivammaatsu M,Hotchkiss RS,Kaarl IE, et al. Cecal ligation and puncture induceds apoptosis in thymus ,apleen,lungand gut by an endotoxin and TNF-independent pathway. Shock,1997,7:247-253.
[34] Rieux-Lancat F, Ledeisy F, Hovroz C,et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science, 1995, 268:1347-1349.
[35] Elizabeth D E,Papathanassoglon RN,Jan A,et al.Expression of Fas(CD95)and Fas legend on peripheral blood mononuclear cells in critical illness and association with multiorgan dysfunction severity and survival.Crit Care Med,2001 vol,29,NO4:709-718
[36] Hagimoto N,Kuwomo K,Nomoto Y,et al. Apotosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Cell Mol Biol,1997,16:91-101
[37] Papathanasslglou,Moynihan. Expression of Fas(CD95) and Fas ligand on peripheral blood monouclear cells in critical illness and association with multi organ dysfunction severity and survival.Crit Care Med,2001,29:709-718.
[38] Hori,Wada. Plasma sFas and sFas ligand levels in patients with thrombotitic thrombocyto penicpurpura and in those with disseminated intravascular coagulation.Am J Hematol, 1999,61:21-25.
[39] Adrie,Bachelet.Mitochondrial membrane potential and apoptosis peripheral blood monocytes in severe human sepsis.Am J Respir Crit Care Med, 2001,164: 389-395.
[40] Hotchkiss, Swanson. Overexpression of Bcl2 in transgenic mice decreases apoptosis and improves survival in sepsis.J Immunol,1999,162:4148-4156.
[41] Jimenez ME, Watson W G, Parodo J, et al. Dysregulated expression of neutrophil apotosis in the systemic inflammatory response syndrome. Arch Surg, 1997,132:1263-1270.
[42] Hotchkiss RS Swanson PE,Freeman BD,et al Apoptosic cell death in patients with sepsis shock and multiple organ dysfunction.Crit Care Med, 1999, 27: 1230-1251
[43] Nolan B,Collette H,Baker S,et al.Inhibition of neutrophil apoptosis after sever trauma is NF-kappabeta dependent.Journal of Trauma 2000vol 48,NO4:599-6
[2] Sandig V, Youil R,Bett AJ,et al. Optimization of the helper-dependent adenovirvus system for production and potency in virvo.[J] Proc Natl Acad Sci 2000; 97(3): 1002-1007
[3] Fathallah Shaykh HM, Kafrouni AI, Zhao LJ, Smith GM, Forman J. Gene transfer into brain parenchyma elicits antitumor effects. [J] Cancer Res, 2000; 60(1): 1797-1799
[4] Schoggins JW, Gall JG, Falck-Pedersen E. Subgroup B and f fiber chimeras eliminate normal adenovirus type 5 vector transduction in vitro and in vivo. [J] Virol, 2003, 77(2): 1039-1048.
[5] Lin H,Parmacek MS,Morle G, et, al.Expression of recombinant gene in myocardium in vivo aflerdirect injection pf DNA[J]. Circulation, 1990, 82(6): 2217-2221
[6] Xing Z, Braciak Z, Jordana M, et al.Adenovirus-mediated cytokine gene transfer at tissue sites. Overexpression of IL-6 induces lymphocytic hyperplasia in the lung [J] Immunol 1994,153(11): 4059 - 4069
[7] Mohr L, Shankara S, Yoon SK, et ai. Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene. [J] Hepatology, 2000; 31(3): 606-614
[8] Bout A, Perricaudet M, Basking et al.Lung gene therapy:in vivo adenovirusmediated gene transfer to rhesus monkey airway epithelium. Hum Gene ther.1994; 5(1):3-10
[9] Maruyama H, Rakow TL, Maruyama IN,.Synaptic exocytosis and nervous system development impaired in caenorhabditis elegans unc-13 mutants. [J]Neuroscience, 2001,104(2):287-294.
[10] Li JJ, Ueno H, Pan Y, et al. Percutaneous transluminal gene transfer into canine myocardium in vivo by replication-defective adenovirus, [J]Cardiovasc Res,1995,30(1):97.
[1] Shimada H,Moriwaki Y, Kurosawa H, et al.Infammatory mediator and organ dysfunction syndrome.Nippon Geka Gakkai Zasshi 1998 Aug:99(8):490-6
[2] Murakami M,Murai N,Kusano M,Organ failure during the perioperative period:pathophysiology and strategy. Nippon Geka Gakkai Zasshi 1998 Aug:99(8): 518-22.
[3] Kushimoto S,Yamaoto Y.SIRS:clinical entity, definitions,and the significance. Nippon Rinsho 1999 Jan; 57(1): 227-35.
[4] Sato N,Endo S,Ikeda K,et al.SIRS in surgical stress.Rinsho Byori 2000 Jan;48(6):521-6
[5] Hirota M,Nozawa F, Okabe A,et al.SIRS and CARS:discussion based on the pathologic condition of acute pancreatitis.Rinsho Byori 2000 Jan;48(6):527-32.
[6] 胡森，盛志勇。MODS动物模型研究进展。中国危重病急救医学，1999，8(11)：504—507。
[7] Bhatti AR, Micusan VV.A mouse modle for staphylococcal entreotoxins toxicity.Microbiol 1996;86(349):247-53.
[8] Hu Sen, Sheng Zhi-yong,Zhou Bao-tong,et al study on delay two-phase mulitiple organ dysfunction syndrome Chin Med J, 1998,111:101-108.
[9] Soreide E,Harboe S,Sondenaa K,et al.Severe ARDS may cause right heart failure with extreme hepatomegaly but without hepatic failure[J].Acta Anaesthesiol Scand,2002,46(7):906-907.
[10] Hristova M,Yordanov M, Ivanvska N,Effrct of gangchinoline in murine modles of multiple organ dysfunction syndrome and septic shock[J] Inflamm Res,2003,52(1): 1-7.
[11] Scillia P, Kafi S A,Melot C,et al.Oleic acid -induced lung injury:thinsection CT evaluation in dogs[J]Radiology,2001,219(3):724-731.
[12] Davidson KG,Berstrn AD,Barr HA, et al.Lung function,permeability,and surfactant composition in oleic acid induced acute lung injury in ratsJ] Am J Physiol Lung Cell Mol Physiol,2000,279(6):L1091-1102.
[1] FangWH,YaoYM,ShiZY, etal. 2002. Lipopolysaccharide-binding protein and lipopolysaccharide receptor CD14 gene expression after thermal injury and its potential mechanism. J Trauma,2002,53:957～967.
[2] Holmes CL,Russell JA,Walley KR.Genetic polymorphisms in sepsis and septic shock:role in prognosis and potential for therapy.chest,2003,124:1103-1115.
[3] Khadaroo RG, Fan J,Powers KA et al.Impaired induction of IL-10 expression in the lung following hemorrhagic shock.Shock,2004,22:333-339.
[4] Senftleben U,Karin M.The IKK/NF-κB pathway.Crit Care Med,2002,30:S18-26.
[5] Takeda K,Kaisho T, Akira.Toll-like receptors. Annu Rev Immunol, 2003, 21: 335-376
[6] 萨姆布鲁克 J，弗里奇 EFy，曼尼阿蒂斯 T 著，金冬燕。黎孟枫译：分子克隆实验指南(第二版) 科学出版社，北京 1992，P881—898。
[7] Soslow RA,Dannenberg AJ,Rush D,et al.cox-2 is expressed in human pulmonary,colonic,and mammary tumors.Cancer,2000,87(12):2637-2645
[8] Yves Le Tulzo, Robert Shenkar, Debra Kaneko, et al.Hemorrhage Increases Cytokine Expression in Lung Mononuclear Cells in Mice. Involvement of Catecholamines in Nuclear Factor-κB Regulation and Cytokine Expression J.Clin. Invest. 1997 99:1516-1524
[9] Keith R. Walley, TreenaE. Et al.Modulation of Proinflammatory Cytokines by Nitric Oxide in Murine Acute Lung Injury Am. J. Respir. Crit. Care Med. 1999; 160:698-704
[10] E. Abraham; R. Wunderink; H. Silverman; T. M. et al.Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study GroupJAMA, Mar 1995; 273:934 - 941.
[11] C. J. Fisher Jr; J. F. Dhainaut; S. M. Opal; et al.Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase Ⅲ rhIL-1ra Sepsis Syndrome Study GroupJAMA, Jun 1994; 271:1836 - 1843.
[12] Kox WJ,Volk T, Kox CN. Immunomodulatory therapies in sepsis.[J].Intensive Care Med,2000,26(Suppl 1):S124-128.
[13] Huber TS,Gaines GC,Welbom B,et al. Anticytokine therapies for acute inflammation and the systemic inflammatory response syndrome: IL-10 and ischemia/reperfusion injury as a new paradigm. [J]Shock,2000,13(6):432-434
[14] Marumo T, Schini-kerth VB,Busse R.Vascular endothelial growth factor activates nuclear factor -kappaB and induces monocyte chemoattractant protein- 1 in bovine retinal endothelial cells[J].Diabetes, 1999,48(5)/: 1131-1138
[15] Yamamoto Y, Gaynor RB, Therapeutic potential of inhibition of the NF-kB pathway in the trearment of inflammation and cancer[J]. J Clin Invest, 2001,107(2): 135-142
[16] Barnes PJ, Anti-inflammatiory actions of glucocorticoids: molecular mechanism [J]. Clin Sci(Colch), 1998, 9496): 557-566
[17] Meng L,Mohan R,Kwoh BH,et al.Epoxomicin,a potent and selective proteasome inhibitor, exhibits in vivo anti-inflammatory activity[J].Pro Natl Acad Sci USA, 1999,96(180:10403-10408
[18] Zandi E, Chen Y, Karin M, et al. Direct Phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappab-bound substrate[J]. Science, 1998,281:1360-1363
[19] Hess DC,Howard E,Cheng C,et al.hypetonic mannitol loading of NF-ksppaB transcription factor decoys in human brain microvascular endothelial cells blocks upregulation of ICAM-1 [J].Stroke,200,31 (5): 1179-1186
[20] Grisenbach V, Scheid P, Hillery E,etal Anti-inflmmatory gene therapy directed at airway epithelium [J] Gene Ther,2000,7:306-313
[21] Marcel L,Florian G, Ines B, et al. Tumor necrosis factor induced hypatocyte apoptosis proceeds liver failure in experimental murine shock models.Am J Pathol, 1995,146:1220-1226.
[22] Hivammaatsu M,Hotchkiss RS,Kaarl IE, et al. Cecal ligation and puncture induceds apoptosis in thymus,apleen,lungand gut by an endotoxin and TNF-independent pathway. Shock, 1997,7:247-253.
[23] Efron PA,Tinsley K,Minnich DJ et al.Increased lymphoid tissue apoptosis in baboons with bacteremic shock.Shock 2004,21:566-571.
[24] Guillon V, Tribut O,Amlot L,et al.Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcame.Shock,2002,18:487-494.
[25] ONeill AJ,Doyle BT, Moloyy E et al.Gene expression profile of inflammatory neutrophils: alterations in the inhibitors of apoptosis proptosis protein during spontaneous and delayed apoptosis.Shock,2004,21:512-518.
[26] Tinsley KW, Grayson MH,Swanson PE et al.Sepsis induces apoptosis and profound depletion of splenic interdigiting and follicular dendritic cells.J Immunol,2003,171:909-914.
[27] Woodside KJ,Spies M,Wu XW et al.Decreased lymphocyte apoptosis by anti-tumor necrosis factor antibody in Peyers patches after severe burn.Shock,2003,20:70-73.
[28] Rieux-Lancat F, Ledeisy F, Hovroz C,et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science, 1995, 268:1347-1349.
[29] Elizabeth D E,Papathanassoglon RN,Jan A,et al.Expression of Fas(CD95)and Fas legend on peripheral blood mononuclear cells in critical illness and association with multiorgan dysfunction severity and survival.Crit Care Med,2001 vol,29,NO4:709-718
[1] [1] Tilney NL,Bailey GL,Mogan AP, et al. Sequential system failure after rupture of abdominal aortic aneurysms:an unsolved problem in postoperative care.Ann Surg 1973;178(2)117-122.
[2] Eiseman B,et al.Multiple organ failure. Surg Gynecol Obsted 1977; 144: 323-326
[3] Yao YM, Redl H, Bahrami S,et,al.The inflammatory basis of trauna/shock-associated multiple organ failure [J]Inflam Res, 1998,47:201
[4] Baue AE.Multiple,progress, or sequential system failure:a syndrome of the 1970s.Arch Surg 1975;110(7):779-781.
[5] Fry DE,Pearlstein L,Fulton RL,et al. Multiple system organ failure: the role of uncontrolled infection.Arch Surg 1980; 115(2): 136-140.
[6] Goris JA, et al. Multiple- organ failure:generalized autodestructive inflammation? Arch Surg 1985; 120: 1109-1115.
[7] Bunt TJ.Non-directed relaparotomy for intra-abdominal sepsis:a futile procedure.Am Surg 1986;52(6):294-298
[8] 周韶霞，邱海波，王爱琴，多器官功能障碍综合征与全身炎症反应综合征[J]．铁道医学，1998，26(1)：4
[9] Bone RC,Balk RA,Cerra FB,et al.The ACCP/SCCM Consensus conference on sepsis and organ failure [J].Chest, 1992,101 (6): 1644.
[10] Bone R C,Immunologic dissonance:a continuing evolution in our cmderstanding of the systemic inflammatory response syndrome and the multiple organ dysfunction syndrome.Ann Interm Med, 1996,125:680-681.
[11] Bone R C. Sir Isaac menton:sepsis,SIRS,and CARS.Crit Care Med, 1996, 24(7): 1125-1128
[12] Hivamaatsu M,Hotchkiss R S,Kaarl IE,et al.Cecal ligation and puncture (CLP)induced apoptosis in thymus,apleen,lung and gut by an etdotoxin and TNF-independent pathway.Shock, 1997,7:247-253.
[13] Rieux-Lancat F, Ledeist F, Hovroz C,et al. Mutation in Fas associated with human-Lymphoproliferative-syndrome-and-autoimmunity.Science, 1995,268:1347-1349.
[14] Elizabeth D E,Papathanassoglon RN,Jan A,et al.Expression of Fas(CD95)and Fas legend on peripheral blood mononuclear cells in critical illness and association with multiorgan dysfunction severity and survival.Crit Care Med, 2001 vol, 29, NO4:709-718
[15] Jimenez ME,Watson W G,Parodo J,et al.Dysregulated expression of neutrophil apotosis in the systemic inflammatory response syndrome.Arch Surg, 1997, 132: 1263-1270.
[16] Nolan B,Collette H,Baker S,et al.Inhibition of neutrophil apoptosis after sever trauma is NF-kappabeta dependent.Journal of Trauma 2000 vol 48,NO4:599-605
[17] Westendorp RGL,Langer mans JAM,Huizinga TWJ,et al.Genetic influence on cytokine.Lancent1997;349:170-173.
[18] van Deventer SH,Stokker P.Genomice of the sepsis syndrome.In: Marshall JC,Cohen J(eds) Immune response in the critically ill.Berlin:Springer-Verlag, 2000, 22-36
[19] Muzio M,Mantovani A.Toll-like receptors.Microbers Infect,2002,2:251-255.
[20] Sen R, Bzltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a.posttranslational mechanism. [J]. Cell,1986,47:921-928
[21] Rahman I,MacNee W. Role of transcription factors in inflammatory lung diseases. Thorax,1998;53:601-612
[22] Karin M,Ben-Neriah Y, Phosphorylation meets ubiquination:the control of NF-kB activity[J].Annu Rev Immunol.2000,18,621-663
[23] Bothrer H,Nawroth PP.Nuclear factor Kb-a new therapeutic approach?Intensive Care Med,1998,24:1129-1130.
[24] Blackwell TS,Christman JW.The role of nuclear factor-kappaB in cytokine gene regulation.Am J Respir cell Mol Biol, 1997,17:3-9.
[25] Nemeth ZH,Hasko G,Vizi ES.Pyrrolidine dithiocarbamate augements IL-10,inhibits TNF-alpha,MIP-1 alpha,IL-12 and nitric oxide production and protects from the lethal effect of endotoxin.Shock,1998,10:49-53.
[26] Lo CJ,Cryer HG, Fu M,et al.Regulation of
[27] 钟林。内皮细胞与多器官功能不全。见：罗正，主编。休克学。第一版。天津：天津科学技术出版社，2001，812—820。
[28] Nakamori Y, Koh T, Ogura H,et al.Enhanced expression of intranuclear NF-kappa B in primed polymorphonuclear leukocytes in systemic inflammatory response syndrome patients.J Trauma,2003,54(2):253-260.
[29] Kettritz R,Choi M,Rolle S,et al.Integrin and cytokines activate nuclear transcription factor-kappaB in human neutrophils.J Biol Chem,2004,279(4): 2657-2665
[30] Abraham E.Nuclear factor-kappaB and its role in sepsis-associated organ failure.J Infect Dis,2003,187(Suppl 2)S364-S369
[31] Foulds S,Galustain C,Mansfield AO,et al.Transcription factor NF-kappa B expression and postsurgical organ dysfunction.Ann Surg,2001,233:70-78
[32] Mustapha S,Kirhner A,De Moissac D,et al. A direct requirement of nuclear factor-kappa B for suppression of apotosis in ventricular myocytes.Am J Physiol Heart Circ Physiol,2000,279(3):H939-945
[33] Marumo T, Schini-kerth VB,Busse R.Vascular endothelial growth factor activates nuclear factor -kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells[J].Diabetes, 1999,48(5)/: 1131-1138
[34] Yamamoto Y, Gaynor RB, Therapeutic potential of inhibition of the NF-kB pathway in the trearment of inflammation and cancer[J]. J Clin Invest, 2001,107(2): 135-142
[35] Barnes PJ, Anti-inflammatiory actions of glucocorticoids: molecular mechanism [J]. Clin Sci(Colch), 1998, 9496): 557-566
[36] Meng L,Mohan R,Kwoh BH,et al.Epoxomicin,a potent and selective proteasome inhibitor, exhibits in vivo anti-inflammatory activity[J].Pro Natl Acad Sci USA, 1999,96(180:10403-10408
[37] Zandi E, Chen Y, Karin M, et al. Direct Phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappab-bound substrate[J]. Science, 1998,281:1360-1363
[38] Hess DC,Howard E,Cheng C,et al.hypetonic mannitol loading of NF-ksppaB transcription factor decoys in human brain microvascular endothelial cells blocks upregulation of ICAM-1 [J].Stroke,200,31 (5): 1179-1186
[1] Tilney NL,Bailey GL,Mogan AP,et al. Sequential system failure after rupture of abdominal aortic aneurysms :an unsolved problem in postoperative care.Ann Surg 1973;178(2)117-122.
[2] Schuster HP Infection as a cause of multiple organ failure. Definition, pathophysiology and diagnostic parameters.[J] Anasth intensivether Notfall Med,1989,24(4):206-211.
[3] YaoYM, RedIH, Bahram S, et al The inflammatory basis of trauma/ shock- associated multiple organ failure. [J] Inflamm Res, 1998, 47(5): 201-210.
[4] Bone RC,Balk RA,Cerra FB,et al.The ACCP/SCCM Consensus conference on sepsis and organ failure [J].Chest,1992,101(6):1644.
[5] Bone R C,Immunologic dissonance:a continuing evolution in our cmderstanding of the systemic inflammatory response syndrome and the multiple organ dysfunction syndrome.Ann Interm Med, 1996,125:680-681.
[6] Kox WJ,Volk T,Kox CN. Immunomodulatory therapies in sepsis.[J].Intensive Care Med, 2000,26(Suppl1):S124-128.
[7] Huber TS,Gaines GC, Welbom B,et al. Anticytokine therapies for acute inflammation and the systemic inflammatory response syndrome: IL-10 and ischemia/reperfusion injury as a new paradigm. [J]Shock,2000,13(6):432-434
[8] Kerr JF,Wyllie AH,Currie AR .Apoptosis; A basic biological phenomenon with wide-ranging implications in tissue kinitics. Br J Cancer 1972;26(4):239-257.
[9] Kerr JF,Winterford CM,Harmon BV.Apoptosis .its significance in cancer and cancer therapy. Cancer1994;73(8):2013-2026.
[10] Ogawa N,Dang H,Talal N.Apoptosis and autoimmunity.J Autoimmun 1995; 8(1): 1-19.
[11] White E,Sabbatini RDebbas M,et al.The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha.Mol Cell Biol.1992;12(6):2570-80
[12] Gougeon ML, Montagnier L.Apoptosis in AIDS.Science 1993;260(5112): 1269-1270.
[13] Raff MC,Barres BA,Burne JF,et al.Programmed cell death and the control of cell survival: lesions from nervous system.Science 1993;262(5134):695-670
[14] Thompson CB.Apotosis in the pathogenesis and treatment of disease. Science 1995;267(5203):1456-1462.
[15] Ayala A,Karr SM,Evans TA,et al.Factors responsible for peritoneal granulocyte apoptosis during sepsis J Surg Res,1997,69(1):67-75.
[16] Meldrum DR,Tumor necrosis factor in the heart .Am J Physiol, 1998, 274(3pt2): R577-595
[17] Hamada E,Nishida T,Uchiyama Y, et al. Activation of kupffer cells and caspase-3 involved in rat hepatocyte apoptosis induced by endotoxin.J Hepatol 1999;30(5):807-818
[18] Leist M,Grantner F,Bohlinger I, et al.Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure experimental murine shock models.Am J Pathol 1995;146(5):1220-1234.
[19] Leist M,Grantner F,Naumann H,et al. Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepototoxins. Gastroenterology 1997; 112(3): 923-924.
[20] Wang Jianghuai,Redmond HP,Watson RWG, et al.Role of lipopolysaccharide and tumor necrosis factor-alpha in induction of hepatocyte necrosis. Am J Physiol, 1995,269(2pt1):G297-304.
[21] Keel M,Ungethum U,Steckholzer U,et al.Interleukin -10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis., Blood,1997,90(9):3356-3363.
[22] Cheng J ,T Zhou, C Liuet,et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule Science, 1994,263:1759.
[23] Ungethwn U,Keel M,Trentz Q,et al.Increased expression of apoptosis-inducing proteins Fas antigen and Fas ligand on mononuclear cells of septic patients. Langenbecka Arch Chir Suppl Kongressbd,1997,114:623-625.
[24] Ertel W,Keel M,Ungethum U,et al.Proinflammatory cytokines regulate apoptosis of granulocytes during systemic inflammation. Langenbecka Arch Chir Suppl Kongressbd, 1997,114:627-629.
[25] Alfred Ayala, Ying Xin Xu, Carol A. Ayala, et al.Increased Mucosal B-Lymphocyte Apoptosis During Polymicrobial Sepsis Is a Fas Ligand But Not an Endotoxin-Mediated Process Blood, Feb 1998; 91: 1362 - 1372.
[26] Williams TE,Ayala A,Chaudry TH.Inducible macrophage apotosis following sepsis is mediated by cysteine protease activation and nitric oxide release. J Surg Res,1997,70(2):113-118.
[27] Ford H, Watkins S, Reblock K, et al .The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis. J Pediatr Surg, 1997, 32(2):275-282.
[28] Marchant A,Deviere J,Byi B,et al. Interleukin-10 production during septicaemia. Lancet, 1994,343:707.
[29] Neidhardt, Regula MD; Keel, Marius MD; Steckholzer, Ursula BS et al. Relationship of Interleukin-10 Plasma Levels to Severity of Injury and Clinical Outcome in Injured Patients. Journal of Trauma-Injury Infection & Critical Care. 1997,42(5):863-871.
[30] Ayala A, Chaudry H. Immune dysfunction in murine polymicrobial sepsis: mediators, macrophages, lymphocytes and apoptosis. Shock, 1996, 6 (suppl1): S27-38.
[31] Cox GIL-10 enhances resolution of pulmonary inflammatory in vivo by promoting apotosis of neutrophils.Am J Physiol,1996,271(4pt1):L566-571.
[32] Marcel L,Florian G, Ines B, et al. Tumor necrosis factor induced hypatocyte apoptosis proceeds liver failure in experimental murine shock models.Am J Pathol, 1995,146:1220-1226.
[33] Hivammaatsu M,Hotchkiss RS,Kaarl IE, et al. Cecal ligation and puncture induceds apoptosis in thymus ,apleen,lungand gut by an endotoxin and TNF-independent pathway. Shock,1997,7:247-253.
[34] Rieux-Lancat F, Ledeisy F, Hovroz C,et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science, 1995, 268:1347-1349.
[35] Elizabeth D E,Papathanassoglon RN,Jan A,et al.Expression of Fas(CD95)and Fas legend on peripheral blood mononuclear cells in critical illness and association with multiorgan dysfunction severity and survival.Crit Care Med,2001 vol,29,NO4:709-718
[36] Hagimoto N,Kuwomo K,Nomoto Y,et al. Apotosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Cell Mol Biol,1997,16:91-101
[37] Papathanasslglou,Moynihan. Expression of Fas(CD95) and Fas ligand on peripheral blood monouclear cells in critical illness and association with multi organ dysfunction severity and survival.Crit Care Med,2001,29:709-718.
[38] Hori,Wada. Plasma sFas and sFas ligand levels in patients with thrombotitic thrombocyto penicpurpura and in those with disseminated intravascular coagulation.Am J Hematol, 1999,61:21-25.
[39] Adrie,Bachelet.Mitochondrial membrane potential and apoptosis peripheral blood monocytes in severe human sepsis.Am J Respir Crit Care Med, 2001,164: 389-395.
[40] Hotchkiss, Swanson. Overexpression of Bcl2 in transgenic mice decreases apoptosis and improves survival in sepsis.J Immunol,1999,162:4148-4156.
[41] Jimenez ME, Watson W G, Parodo J, et al. Dysregulated expression of neutrophil apotosis in the systemic inflammatory response syndrome. Arch Surg, 1997,132:1263-1270.
[42] Hotchkiss RS Swanson PE,Freeman BD,et al Apoptosic cell death in patients with sepsis shock and multiple organ dysfunction.Crit Care Med, 1999, 27: 1230-1251
[43] Nolan B,Collette H,Baker S,et al.Inhibition of neutrophil apoptosis after sever trauma is NF-kappabeta dependent.Journal of Trauma 2000vol 48,NO4:599-6